Clinical Trials Logo

Clinical Trial Summary

Approximately one-fifth of community dwelling older adults exhibits mild cognitive impairment (MCI), and despite this being an early caregiving role, assisting a person with MCI is stressful and challenging. The purpose of this study is to develop and pilot test a communication-based psychoeducation program for persons with MCI and their care partners to improve their interpersonal management of MCI. The study team will be recruiting 30 adults throughout the US, though predominantly in GA, to serve on a virtual advisory board, which will meet every other week via webinar software to develop a virtual psychoeducation program for care partner dyads.


Clinical Trial Description

Approximately one-fifth of community dwelling older adults exhibits mild cognitive impairment (MCI), and despite this being an early caregiving role, assisting a person with MCI is stressful and challenging. The purpose of this study is to develop and pilot test a communication-based psychoeducation program for persons with MCI and their care partners to improve their interpersonal management of MCI. The investigators will be recruiting 30 adults throughout the US, though predominantly in GA, to serve on a virtual advisory board, which will meet every other week via webinar software to develop a virtual psychoeducation program for care partner dyads. Advisory board members will include persons with MCI and care partners for persons with MCI. Advisory Board recruitment will be made directly by investigators via phone or email. In the second phase of the study, the study team will test the virtual program developed through the advisory board in four groups of 6 MCI/care partner dyads (n=48). Study information and recruitment materials will be sent to neurology partners throughout Georgia to make study information available to any interested patients with MCI. Verbal consent will be obtained by investigators over the phone or through webinar software, and participants will complete surveys through RedCAP software baseline, 4 weeks post-, and 8 weeks post-intervention. A subsample of n=30 intervention participants will be invited to engage in a virtual interview with staff to examine the feasibility and acceptability of their intervention experience. Total respondent burden for advisory board members won't exceed 36 hours; and respondent burden for intervention participants (including those doing interviews) will not exceed 26 hours. Data will not be made publicly available, and participants will be assigned a coded identifier with the password-protected document containing the key stored separately from data files. Designated study staff will have access to this key. All study files will require a password for access, and only study personnel will have access to the file passwords. Audio recordings will be destroyed following completion of the study and transcription of the interviews. As the study is virtual, all quantitative data will be collected online, and interviews will be conducted through webinar software. The scope of topic areas covered in the advisory board, intervention, and interviews will pertain to experiences, challenges, and coping strategies of persons with MCI and their care partners. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05423912
Study type Interventional
Source Emory University
Contact Lindsay Prizer, PhD
Phone 678-788-3128
Email lprizer@emory.edu
Status Recruiting
Phase N/A
Start date February 8, 2023
Completion date May 2024

See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A